Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Worldwide Initiative for Diabetes Education (World-Wide IDE) is a non-profit organization dedicated to providing high-quality, evidence-based medical education to healthcare professionals globally. Founded by leading experts in endocrinology, the organization focuses on improving the management and treatment of diabetes and its complications through various educational programs, workshops, and digital resources. Its mission is to bridge the gap between clinical research and practice, particularly in underserved regions. The initiative collaborates with international medical societies and academic institutions to standardize diabetes care and promote the latest therapeutic advancements. Its activities are primarily supported by independent educational grants from the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Worldwide Initiative for Diabetes Education.